Aegerion Pharmaceuticals, Inc.
http://www.aegerion.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Aegerion Pharmaceuticals, Inc.
Deals In Depth: October 2022
Two $1bn+ alliances were penned in October. Financing reached $7.7bn in biopharma, $636m in device, and $140m in diagnostics.
Medtech Challenged To Build On 2021 Amid Threats Of Recession: Views From Industry Leaders
Strong headwinds beset the medtech industry as 2022 draws to a close, including supply chain, fundraising and labor shortages. However, optimism prevailed among medtech industry leaders discussing EY’s annual Pulse of the Industry medical technology report and related topics at AdvaMed’s 2022 MedTech Conference.
Medtech Challenged To Build On 2021 Amid Threats Of Recession: Views From Industry Leaders
Strong headwinds beset the medtech industry as 2022 draws to a close, including supply chain, fundraising and labor shortages. However, optimism prevailed among medtech industry leaders discussing EY’s annual Pulse of the Industry medical technology report and related topics at AdvaMed’s 2022 MedTech Conference.
Minute Insight: Thermo Fisher Buys Diagnostics Company The Binding Site For $2.6Bn
Birmingham, UK-based The Binding Site and its 1,100 employees will now fall under Thermo Fisher’s expanding umbrella.